European equities traded in the US as American depositary receipts were little changed late Tuesday morning, edging 0.01% lower to 1,604.02 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biotech firm Evaxion (EVAX) and telecommunications company Nokia (NOK), which rose 4.5% and 1.7% respectively. They were followed by lender Banco Santander (SAN) and semiconductor company Sequans Communications (SQNS), which were up 1.3% and 0.2% respectively.

The decliners from continental Europe were led by 3D printer company Materialise (MTLS) and accommodations booking site trivago (TRVG), which fell 2.1% and 1.8% respectively. They were followed by consumer goods giant Unilever (UL) and pharmaceutical company Sanofi (SNY), which were down 1.6% and 1.1% respectively.

From the UK and Ireland, the gainers were led by lender HSBC (HSBC) and pharmaceutical company Silence Therapeutics (SLN), which advanced 4% and 3.2% respectively. They were followed by biopharmaceutical companies Akari Therapeutics (AKTX) and Mereo BioPharma Group (MREO), which increased 3.1% and 1% respectively.

The decliners from the UK and Ireland were led by cruise line operator Carnival (CUK) and biotech firm Autolus Therapeutics (AUTL), which dropped 4.3% and 3.9% respectively. They were followed by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and NuCana (NCNA), which lost 3.3% and 1.2% respectively.